Efficacy of a Single Dose of Albendazole for Treating Ascaris lumbricoides in Schoolchildren in Northwest Ethiopia: An Open-Label Trial Examining Re-Infection Rates and Contributing Factors - Summary - DentalSpire
Advertisement
Efficacy of a Single Dose of Albendazole for Treating Ascaris lumbricoides in Schoolchildren in Northwest Ethiopia: An Open-Label Trial Examining Re-Infection Rates and Contributing Factors
To evaluate the therapeutic efficacy of a single-dose Albendazole (400 mg) against A. lumbricoides, assess re-infection rates, and identify factors associated with re-infection among schoolchildren in northwest Ethiopia, highlighting its public health significance.
Key Findings:
The prevalence of A. lumbricoides in the district was 41.3% despite ongoing deworming efforts, indicating a need for enhanced intervention strategies.
Re-infection can occur as early as 2 months post-treatment, with intensity reverting to pre-treatment levels within 12 months, suggesting rapid reinfection dynamics.
Factors contributing to re-infection include poor hygiene practices and waste management, necessitating targeted educational programs.
Interpretation:
The study highlights the limited efficacy of a single dose of Albendazole in preventing re-infection of A. lumbricoides among schoolchildren, emphasizing the urgent need for improved hygiene and sanitation measures alongside drug administration to enhance public health outcomes.
Limitations:
The study was conducted in a single district, which may limit generalizability; future studies should consider multi-site approaches.
Potential biases in self-reported hygiene practices and adherence to follow-up; employing objective measures could strengthen findings.
Conclusion:
Periodic assessments of drug efficacy and re-infection rates are crucial for developing effective control strategies against A. lumbricoides, indicating that MDA alone may not suffice for elimination and highlighting the need for integrated approaches.
Systematic review identifies key prognostic factors for TMD pain and function but emphasizes low-certainty evidence and need for more rigorous research.
A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.
